Clinical trial
Individualized Targeting and Neuromodulation of Late-Life Depression
NCT04543773 is registered in ClinicalTrials.gov with University of New Mexico as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Individualized Targeting and Neuromodulation of Late-Life Depression
- Lead sponsor
- University of New Mexico
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- October 1, 2024
- Completion date
- September 1, 2027
- Enrollment
- 24 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.